Recent News

Class Action Alert: Becker v. Bank of New York Mellon Notice of Pendency of Class Action

9/27/2017 - By Order dated September 14, 2017, the Court approved the proposed form, content, and manner of giving notice to potential class members that a Class had been certified in Becker v. The Bank of New York Mellon Trust Company, N.A., et al., Civil Action No. 11-cv-6460.  The “Notice of Pendency of Class Action” (the “Notice”), available here, describes the action and class members’ related rights in detail.  The “Class” is defined as:

Read Article

Court Grants Final Approval of Settlement in In re DFC Global Securities Litigation

9/20/2017 - On September 20, 2017, Judge Berle Schiller of the United States District Court for the Eastern District of Pennsylvania granted final approval of the settlement and plan of allocation in In re DFC Global Corp. Securities Litigation, C.A. No. 13-cv-6731, a securities fraud class action that challenged statements made by DFC Global Corp., a payday lender with core operations in the United Kingdom, and members of its senior management team, regarding the company’s lending practices.  The settlement of this action included a cash payment of $30,000,000.

Read Article

Court Allows Cost of Insurance Increase Case to Proceed Against Lincoln National Corp. and Lincoln National Life Insurance Co.

9/11/2017 - Judge Gerald J. Pappert of the United States District Court for the Eastern District of Pennsylvania has denied in large measure defendants’ motion to dismiss the Consolidated Class Action Complaint that plaintiffs filed on April 19, 2017, in In re Lincoln National COI Litigation, C.A. No.

Read Article

Columbia Law School Blue Sky Blog Publishes BR&B Attorneys' Article About Mandatory Arbitration

8/28/2017 - The Columbia Law School’s Blue Sky Blog published an article by BR&B partner Samuel M. Ward and associate Michael A. Toomey rebutting a prior article by Harvard Law School Professor Hal S. Scott.  Professor Scott argued that mandatory arbitration provisions in corporate charters would be good for stockholders and that the current system of federal oversight is sufficient to inhibit and remedy corporate fraud.  BR&B’s attorneys explain that, as stated by the U.S. Supreme Court and U.S.

Read Article

Law360 Published BR&B Attorneys' Article Addressing SEC Commissioner's Controversial Mandatory Arbitration Remarks

8/9/2017 - Law360 published an article by BR&B partner Samuel M. Ward and associate Michael A. Toomey that addresses remarks made by SEC Commissioner Piwowar during a July 17, 2017 Q&A, in which the Commissioner invited companies to include mandatory arbitration provisions in their corporate charters.  This signaled a potential change to the SEC’s position on such arbitration provisions.  The Law360 article explains how such arbitration provisions could inhibit investors’ ability to use the federal securities laws to prevent, correct, and redress corporation malfeasance.

Read Article

Law360 Publishes BR&B Partners' Article on the 15th Anniversary of the Sarbanes-Oxley Act

7/31/2017 - Law360 published an article by BR&B partners Jeffrey W. Golan and Chad A.

Read Article

BR&B Partner's Supreme Court Case Commentary Published by Law360

7/17/2017 - Law360 published an article by BR&B partner Mark R. Rosen on the U.S. Supreme Court’s decision in California Public Employees Retirement System v. ANZ Securities, Inc.  Mr. Rosen’s commentary responds to a Law360 article claiming that the decision is a “significant victory for securities class action defendants.”  As Mr.

Read Article

New York Supreme Court Allows Excessive Compensation Action to Proceed Against Regeneron Pharmaceuticals, Inc., Its Board and Executives

6/29/2017 - The Supreme Court of New York has found that an institutional investor's allegations against Regeneron’s board of directors for paying directors and officers grossly excessive compensation can go forward.  Specifically, Justice Saliann Scarpulla denied a motion to dismiss a stockholder derivative action against the board of directors, chief executive officer (“CEO”) and chief scientific officer (“CSO”) of Regeneron Pharmaceuticals, Inc., a New York corporation.

Read Article

Alert: U.S. Supreme Court Rules That the 3-Year Statute of Repose on Securities Act Claims Is Not Suspended by the Pendency of a Class Action

6/26/2017 - In an important opinion that will affect institutional investors, on June 26, 2017 the U.S. Supreme Court issued a 5-4 decision in California Public Employees’ Retirement System v.

Read Article

New Study Identifies Barrack, Rodos & Bacine Among the Top Plaintiffs' Securities Class Action Firms

6/12/2017 - A report issued by ISS Securities Class Action Services places Barrack, Rodos & Bacine among the most successful plaintiffs’ securities class action firms based on a report of the top 100 U.S. securities class action settlements of all time.

Read Article

Pages